Exome Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-26,400
Closed -$610K 59
2023
Q4
$610K Buy
+26,400
New +$610K 0.6% 45